Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

melanoma

  • Open Access
    Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance
    Simona Serratì, Lucia Raho, Gisella De Giosa, Letizia Porcelli, Roberta Di Fonte, Rossella Fasano, Pedro Miguel Lacal, Grazia Graziani, Rosa Maria Iacobazzi and Amalia Azzariti
    Cancer Biology & Medicine November 2025, 22 (11) 1327-1352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0048
  • You have access
    PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
    Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
    Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
  • You have access
    Single-cell trajectories of melanoma cell resistance to targeted treatment
    Maria Schmidt, Lena Sünke Mortensen, Henry Loeffler-Wirth, Corinna Kosnopfel, Knut Krohn, Hans Binder and Manfred Kunz
    Cancer Biology & Medicine January 2022, 19 (1) 56-73; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0267
  • You have access
    COX-2 as a potential biomarker and therapeutic target in melanoma
    Diana Valentina Tudor, Ioana Bâldea, Mihai Lupu, Teodor Kacso, Eniko Kutasi, Andreea Hopârtean, Roland Stretea and Adriana Gabriela Filip
    Cancer Biology & Medicine February 2020, 17 (1) 20-31; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0339
  • You have access
    Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271
    Weiyu Shen, Yumei Li, Bifei Li, Liping Zheng, Xiaodong Xie, Jingqing Le, Yusheng Lu, Tao Li, Fan Chen and Lee Jia
    Cancer Biology & Medicine August 2019, 16 (3) 498-513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0073
  • You have access
    Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
    Jelena Grahovac, Tatjana Srdić-Rajić, Juan Francisco Santibañez, Marijana Pavlović, Milena Čavić and Siniša Radulović
    Cancer Biology & Medicine May 2019, 16 (2) 247-263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0375
  • You have access
    Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Kim Teresa, Rodabe N. Amaria, Christine Spencer, Alexandre Reuben, Zachary A. Cooper and Jennifer A. Wargo
    Cancer Biology & Medicine December 2014, 11 (4) 237-246; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.002
  • You have access
    Primary Malignant Amelanotic Melanoma in the Female Genital Tract: A Report of Six Cases and a Review of the Literature
    Jusheng An, Lingying Wu, Bin Li, Haizhen Lu, Ning Li and Ma Shaokang
    Chinese Journal of Clinical Oncology October 2008, 5 (5) 383-386; DOI: https://doi.org/10.1007/s11805-008-0383-x
  • You have access
    The Inhibitory Effect of Endostatin and Doxycycline Administration on B16 Melanoma Angiogenesis and Cellular Proliferation
    Lisha Qi, Shiwu Zhang, Danfang Zhang, Xiaojin Yin, Sen Wang and Baochun Sun
    Chinese Journal of Clinical Oncology June 2008, 5 (3) 179-182; DOI: https://doi.org/10.1007/s11805-008-0179-z

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire